{
    "Trade/Device Name(s)": [
        "Dimension Vista AFP Flex reagent cartridge"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K090236",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LOJ"
    ],
    "Summary Letter Date": "April 27, 2009",
    "Summary Letter Received Date": "February 2, 2009",
    "Submission Date": "January 30, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.6010"
    ],
    "Regulation Name(s)": [
        "Tumor-associated antigen immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "Alpha-fetoprotein"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (lithium heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Dimension Vista System"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous sandwich chemiluminescent immunoassay",
        "LOCI technology"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Dimension Vista AFP Flex reagent cartridge using chemiluminescent immunoassay to measure alpha-fetoprotein in serum and plasma as an aid in managing non-seminomatous testicular cancer",
    "Indications for Use Summary": "Quantitative measurement of alpha-fetoprotein in human serum and lithium heparinized plasma on the Dimension Vista System as an aid in managing non-seminomatous testicular cancer, when used in conjunction with clinical evaluation",
    "fda_folder": "Immunology"
}